STUDIES & SURVEYS: Massive Decreases In Drug Payments May Be Coming Your Way

Why This Topic Matters

It helps readers understand why Medicare payment methods and carrier-level billing practices may be under scrutiny and why these topics can affect reimbursement, documentation review, and compliance planning.

Article Sections

1. Medicare overpaid Part B drugs in 2005, says OIG

   Discusses an inspector general report on Medicare Part B drug payment calculations and the broader concern that reimbursement levels may have been too high or too low for different drug codes. It also notes CMS response and the payment methodology context referenced in the article.

2. OIG Allergic To Substandard Care

   Summarizes a second inspector general report focused on allergen immunotherapy services for Medicare beneficiaries, with attention to coverage, documentation, medical necessity, and carrier policy variation. The section also describes CMS response to the report and broader oversight recommendations.